Renal Cancers Terminated Phase 1 Trials for Sorafenib (DB00398)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589550PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney CancerTreatment